Trial Profile
Phase 0 pharmacodynamic study of mycophenolate mofetil in patients with pancreatic cancer [Estudio farmacodinamico Fase "0" de Micofenolato Mofetil (MMF, CellCept) en pacientes con cancer de pancreas]
Status:
Recruiting
Phase of Trial:
Phase 0
Latest Information Update: 25 Mar 2013
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Pancreatic cancer
- Focus Biomarker; Pharmacodynamics
- Acronyms PROYECTO-FIS
- 30 Aug 2011 New trial record